leisure time -WSS

leisure time

author：entertainment 2025-09-27 23:53:37 - browse：81778

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.

For more on what we cover, here’s more on PIPEs; here’s the news from Viking Therapeutics; here’s the latest in MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The high cost of giving birth even with insurance
Next article： 2 US Navy sailors arrested for allegedly spying for China

WSS

Brain 'hot spot' may explain why African Americans feel greater pain

2 US Navy sailors arrested for allegedly spying for China

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

'Ancient DNA,' 23andMe reveal African American ancestries

A new study asks: Are we harming blood donors by taking blood?

OTC birth control: A brief history of over the counter pill design

entertainment

leisure time

focus

Duchenne breakthrough therapy leaves behind pioneering families

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

The cancer drug shortage isn’t new — and neither are the solutions

Stem cell clinics for heart failure: buyer be wary

The cancer drug shortage isn’t new — and neither are the solutions

Dramatically reducing cancer deaths requires the PASTEUR Act

Medicare proposal to cover medical devices draws a mixed reaction

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Cancer drug shortages should be causing more outrage

ProMED, early warning system on disease outbreaks, in peril

hotspot

Humana, CVS hope to turn members into patients at clinics

Listen: PBM conflicts, RSV vaccines, & the future of flu season

'Ancient DNA,' 23andMe reveal African American ancestries

Can food be medicine? And other questions about a new push

ER docs worry over extreme heat as a 'mass casualty event'

ER docs worry over extreme heat as a 'mass casualty event'

entertainment

hotspot

focus

explore